These Analysts Revise Their Forecasts On Abbott Following Q2 Results
1. Abbott's Q2 sales reached $11.14 billion, beating expectations. 2. Adjusted earnings were $1.26, above consensus of $1.25. 3. Adjusted earnings guidance for 2025 was narrowed to $5.10-$5.20 per share. 4. Stock dipped 8.5% despite positive growth rates. 5. Analysts adjusted price targets, with BTIG maintaining a Buy recommendation.